Recurrence Rate of Differentiated Thyroid Cancer in Patients Underwent Post-Radioactive Iodine Ablation Therapy at the Service De Medecine Nucleaire, Centre Hospital Universitaire De Bab El Oued, Algiers, Algeria
| dc.contributor.advisor | Bouyoucef Salah | |
| dc.contributor.author | Temesgen Negash | |
| dc.date.accessioned | 2026-06-22T15:36:36Z | |
| dc.date.available | 2026-06-22T15:36:36Z | |
| dc.date.issued | 2025-05-09 | |
| dc.description.abstract | Introduction: Differentiated thyroid cancer (DTC) is primarily derived from follicular cells and accounts for over 90% of thyroid malignancies. Despite a high disease-free survival rate (98%) following radioactive iodine (RAI) ablation therapy, recurrence rates vary significantly globally. Objective: This study aimed to assess the recurrence rate of DTC through a retrospective crosssectional analysis of patients who underwent RAI therapy. Methods: A sample size of 100 patients with DTC treated at the Service de Médecine Nucléaire was analyzed using specific inclusion/exclusion criteria. Result: The recurrence rate post-RAI therapy was 11% with 6/11(55%) cytological confirmed and 5/11(45%) not confirmed. The study show no associated risk factor for recurrence. Conclusion: the study shows recurrence rate was in the low-risk group but higher than the local region. No predictor associate with recurrence. Recommendation: revise management principle and risk stratification. PET/CT must be included in the follow-up. | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/8375 | |
| dc.language.iso | en | |
| dc.publisher | Addis Ababa University | |
| dc.subject | Differentiated thyroid cancer Radioactive Iodine recurrence | |
| dc.title | Recurrence Rate of Differentiated Thyroid Cancer in Patients Underwent Post-Radioactive Iodine Ablation Therapy at the Service De Medecine Nucleaire, Centre Hospital Universitaire De Bab El Oued, Algiers, Algeria | |
| dc.type | Thesis |